Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
about
Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.Cancer-associated thrombosis.The potential benefits of low-molecular-weight heparins in cancer patientsCancer-associated thrombosis: an overviewTissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in miceInhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanomaUpper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors.Toxicity of bevacizumab in combination with chemotherapy in older patientsVenous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.Risk assessment models for cancer-associated venous thromboembolism.Clinical models and biochemical predictors of VTE in lung cancer.Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: procoagulant nature of osteosarcoma.Venous thromboembolism in patients with head and neck cancer after surgery.Circulating procoagulant microparticles in cancer patients.Association of Peripheral Monocyte Count with Soluble P-Selectin and Advanced Stages in Nasopharyngeal Carcinoma.Mecanismos do tromboembolismo venoso no câncer: uma revisão da literatura.
P2860
Q30496573-272BF1FA-BCD8-45A2-BE87-48CE9534777AQ33389006-EA61BA44-AAA2-40F0-9EC3-C81660A246DBQ33698360-CD2D15F6-DEA3-421F-B7C6-2C50206BC3AAQ34655217-6F35FE99-E113-497D-B6C7-22DC871B6F5CQ35832620-8CDD61A4-61FE-4139-8924-E1BE5CB65CB4Q36179649-2E6F148C-D9C0-4F5B-B527-B50FBC6CDE2EQ36534826-FED0D7E0-A70E-4F9C-9788-B55260AA4670Q36804502-E6B84141-6247-498F-8AE4-BD6D82D2C479Q37190522-7F633C33-82DF-4845-837A-8F741BBA6315Q37956590-9977AB18-9D52-4B76-AB0D-DE99559B1672Q38205701-31EBCB9B-8270-4BA9-904E-5904E26B940FQ39467158-294497AD-C1B8-4638-8D74-6EF3D72E72B0Q43855755-5893F51F-8FD5-4AAA-A599-08D5A2B36C18Q53292843-CD3A219B-B43F-4691-A764-5A2B86AE321CQ55255652-157244F6-FDB4-4D72-85F6-226ED2BEC23BQ55432473-F98BB9CD-E512-49B4-B018-760408802394
P2860
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@en
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@nl
type
label
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@en
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@nl
prefLabel
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@en
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
@nl
P1433
P1476
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model
@en
P2093
P304
P356
10.1016/S0049-3848(09)70137-9
P478
123 Suppl 4
P577
2009-01-01T00:00:00Z